footandmouth
diseas
viru
fmdv
caus
agent
footandmouth
diseas
sever
clinic
acut
vesicular
diseas
clovenhoof
anim
rna
interfer
rnai
mechan
silenc
gene
express
posttranscript
exploit
rapid
antivir
strategi
identifi
efficaci
small
interf
rna
sirna
inhibit
replic
fmdv
candid
sirna
correspond
fmdv
gene
design
synthes
vitro
use
rna
polymeras
report
assay
five
sirna
show
signific
sequencespecif
silenc
effect
express
fusion
protein
plasmid
cotransfect
sirna
cell
furthermor
use
rtqpcr
viral
titrat
viabil
assay
identifi
transient
act
potent
inhibitor
fmdv
replic
cell
infect
fmdv
addit
variat
within
multipl
region
quasispeci
fmdv
retrospect
reveal
sequenc
fmdv
gene
singl
nucleotid
substitut
identifi
main
factor
resist
rnai
data
demonstr
three
sirna
molecul
synthes
rna
polymeras
could
transient
inhibitori
effect
replic
fmdv
footandmouth
diseas
fmd
diseas
clovenhoof
anim
cattl
pig
sheep
goat
patholog
caus
adult
anim
sign
fever
vesicl
mouth
feet
udder
loss
milk
product
also
caus
death
young
anim
haydon
et
al
impact
region
nationwid
outbreak
fmd
pose
sever
econom
problem
loss
unit
kingdom
netherland
taiwan
chen
et
al
saiz
et
al
shih
et
al
thompson
et
al
convent
vaccin
potenti
control
major
epidem
fmd
new
gener
vaccin
base
viral
protein
protein
fragment
nucleic
acid
promis
futur
term
advantag
exist
convent
vaccin
nevertheless
vaccin
still
remain
contenti
owe
limit
exampl
convent
inactiv
viru
vaccin
may
leav
residu
live
viru
vaccin
dna
vaccin
elicit
inadequ
neutral
antibodi
protect
diseas
swine
balamurugan
et
al
ward
et
al
chimer
vaccin
possibl
lead
product
virul
virus
lack
thermost
inactiv
vaccin
product
van
rensburg
mason
furthermor
imper
use
new
antivir
strategi
compens
vaccin
requir
least
day
induc
protect
clinic
diseas
infect
appear
infect
anim
earli
day
postexposur
sinc
discoveri
dsrnainduc
genesilenc
plant
napoli
et
al
neurosporo
crassa
cogoni
macino
decis
unravel
mechan
underl
rnai
phenomenon
worm
caenorhabd
elegan
fire
et
al
rnai
use
power
laboratori
antivir
tool
may
offer
new
therapeut
option
viral
infect
human
immunodefici
viru
bennass
et
al
nekhai
jerebtsova
hepat
b
c
viru
kim
et
al
radhakrishnan
et
al
rendal
sarscov
akerstrom
et
al
wu
et
al
well
valuabl
tool
studi
endogen
gene
function
recent
sever
laboratori
use
rnai
inhibit
footandmouth
viru
infect
cell
cultur
anim
take
form
chemic
synthes
sirna
plasmid
encod
shrna
adenoviru
encod
shrna
chen
et
al
chen
et
al
de
lo
santo
et
al
kahana
et
al
mohapatra
et
al
show
rapid
decreas
fmdv
replic
fmdv
positivestrand
rna
approxim
nucleotid
length
consist
singl
long
open
read
frame
orf
member
picornavirida
famili
belsham
mason
et
al
known
viral
genom
rna
positivestrand
picornavirus
use
messeng
translat
templat
negativestrand
synthesi
might
switch
process
belsham
van
rij
andino
recent
studi
polioviru
gitlin
et
al
influenza
viru
kahana
et
al
show
intriguingli
posit
rna
strand
target
rnai
cleavag
specif
locat
might
result
degrad
full
length
viru
chose
fmdv
specif
target
inhibit
replic
fmdv
encod
structur
protein
contain
argglyasp
rgd
tripeptid
sequenc
gh
loop
respons
bind
fibronectin
cellular
receptor
integrin
mason
et
al
work
made
number
small
interf
rna
sirna
target
gene
fmdv
quickli
effici
synthes
vitro
use
rna
polymeras
test
identifi
multipl
effect
sirna
candid
confirm
sequencespecif
inhibit
independ
enhanc
green
fluoresc
protein
egfp
report
assay
furthermor
three
sirna
valid
transient
inhibit
fmdv
replic
cell
addit
demonstr
viral
popul
consist
variant
spectra
might
obstacl
affect
sirna
inhibit
cell
cultur
vitro
synthesi
sirna
sirna
gener
use
ribomax
express
rnai
system
promega
madison
wi
usa
brief
sequenc
candid
gene
fmdv
sirna
synthesi
select
use
webbas
tool
sirna
target
design
version
promega
http
wwwpromegacomsirnadesign
meet
sequenc
requir
presenc
gn
sequenc
target
rna
need
specif
sequenc
candid
verifi
blast
search
http
wwwncbinlmnihgovblast
dna
templat
vitro
transcript
sirna
contain
rna
polymeras
promot
sequenc
six
extra
nucleotid
upstream
minim
promot
sequenc
addit
two
adenin
nucleotid
ad
end
templat
qin
et
al
scrambledsirna
also
chosen
posit
neg
sirna
control
respect
oligonucleotidedirect
product
small
interf
rna
rna
polymeras
carri
use
ribomax
express
rnai
system
betz
accord
manufactur
instruct
promega
madison
wi
usa
sens
antisens
rna
gener
separ
reaction
anneal
mix
transcript
reaction
incub
min
follow
min
room
temperatur
obtain
small
interf
doublestrand
rna
synthes
rna
polymeras
mixtur
purifi
isopropanol
precipit
follow
ethanol
wash
dri
resuspend
appropri
amount
nucleasefre
water
sirna
aliquot
store
use
human
embryon
kidney
cell
line
hek
cell
babi
hamster
kidney
cell
line
cell
grown
dulbecco
modifi
eagl
medium
dmem
gibco
tm
invitrogen
corpor
grand
island
ny
usa
supplement
heatinactiv
calf
serum
humidifi
atmospher
co
viru
use
infect
fmdv
isol
genbank
access
kindli
provid
prof
jin
ningyi
dept
virolog
militari
veterinari
institut
quartermast
univers
pla
changchun
jilin
growth
isol
titrat
conduct
use
cell
titrat
perform
follow
cell
seed
plate
day
infect
supernat
viral
infect
sampl
serial
dilut
ad
well
per
well
duplic
four
day
infect
tissu
cultur
infect
dose
tcid
calcul
use
reedmuench
formula
reed
muench
recombin
plasmid
contain
whole
length
gene
sequenc
contain
gene
sequenc
construct
follow
fmdv
genom
rna
extract
sampl
fmdvinfect
tcid
ml
subject
three
cycl
freez
thaw
accord
manufactur
instruct
bodi
fluid
viral
dnavir
rna
miniprep
kit
vgene
biotechnolog
ltd
pr
china
viral
rna
revers
transcrib
cdna
use
exscript
tm
rt
reagent
kit
perfect
real
time
takara
accord
manufactur
manual
fragment
bp
fmdv
amplifi
sens
ecoriadapt
primer
antisens
bamhiadapt
primer
bp
sens
ecoriadapt
primer
antisens
bamhiadapt
primer
use
pfu
mastermix
tiangen
biotechnolog
co
ltd
beij
pr
china
pcr
product
clone
uniqu
site
ecori
bamhi
vector
clontech
palo
alto
ca
upstream
egfp
gene
sequenc
insert
check
restrict
enzym
digest
dna
sequenc
report
plasmid
design
gener
util
plasmid
templat
g
mutat
gener
posit
equival
g
variat
use
quikchang
sitedirect
mutagenesi
kit
stratagen
briefli
forward
mutagen
primer
complementari
revers
mutagen
primer
synthes
util
pcr
experi
accord
manufactur
instruct
amplif
reaction
treat
dpni
restrict
enzym
elimin
parent
templat
remain
dna
use
transform
transform
bacteri
cultur
grown
report
construct
sequenc
ensur
authent
purifi
use
nucleobond
xtra
midi
plu
machereynagel
germani
similar
procedur
perform
prepar
report
plasmid
design
forward
mutagen
primer
complementari
revers
mutagen
primer
hek
cell
seed
plate
densiti
cellswel
llwell
fresh
cscontain
dmem
h
transfect
cell
cotransfect
ng
report
construct
ng
sirna
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
scrambledsirna
serv
posit
neg
control
respect
cell
incub
incub
variou
time
point
observ
imag
express
differ
sirna
cotransfect
hek
cell
taken
fluoresc
microscop
olympu
japan
digit
camera
nikon
coolpix
japan
h
transfect
magnif
exposur
time
flow
cytometri
analysi
h
posttransfect
carri
follow
wash
pb
two
time
hek
cell
resusp
pbswell
analysi
facscalibur
becton
dickinson
cell
well
count
analyz
cellquest
softwar
use
mocktransfect
hek
cell
control
valu
calcul
percentag
cell
popul
exceed
fluoresc
intens
control
cell
mean
fluoresc
intens
popul
sirna
transfect
viral
challeng
assay
cell
seed
sixwel
plate
cell
well
serumcontain
dmem
h
transfect
cell
transfect
lg
sirna
use
h
cell
well
sixwel
plate
infect
tcid
viru
viral
suspens
stock
suspens
titrat
tcid
ml
h
adsorpt
inoculum
remov
cell
wash
twice
pb
ph
infect
proceed
dmem
supplement
calf
serum
time
point
h
cell
examin
microscop
light
imag
taken
fluoresc
microscop
olympu
japan
magnif
exposur
time
simultan
sampl
supernat
taken
indic
time
postinfect
pi
h
store
determin
viru
titer
tcid
h
pi
cell
triplic
well
harvest
realtim
quantit
rtpcr
rtqpcr
viral
challeng
assay
viru
titrat
determin
three
time
cell
rna
extract
perform
use
trizol
reagent
molecular
research
center
inc
follow
manufactur
instruct
briefli
h
viral
infect
cell
wash
pb
time
lyse
directli
ad
ml
trizol
reagent
chloroform
ml
ml
isopropyl
alcohol
use
aqueou
phase
separ
precipit
rna
wash
ethanol
total
rna
dissolv
follow
treatment
dnase
rnase
free
takara
dalian
pr
china
total
rna
redissolv
rtqpcr
detect
total
rna
revers
transcrib
cdna
exscript
tm
rt
reagent
kit
perfect
real
time
takara
revers
transcript
mixtur
compris
rna
ng
exscript
tm
rtase
buffer
dntp
mixtur
oligo
dt
exscript
tm
rtase
rnase
inhibitor
realtim
pcr
mixtur
consist
sens
primer
lm
antisens
primer
lm
sybr
premix
extaq
tm
dh
sybr
premix
ex
taq
tm
perfect
real
time
takara
biotechnolog
co
ltd
dalian
pr
china
primer
sequenc
follow
fmdv
sens
primer
fmdv
antisens
primer
bactin
sens
primer
bactin
antisens
primer
pcr
carri
use
instrument
gene
compani
ltd
anneal
temperatur
data
analyz
use
two
standard
curv
method
sirna
transfect
viral
challeng
perform
plate
describ
section
except
amount
seed
cell
sirna
virus
well
sixwel
plate
h
pi
cell
viabil
separ
assess
ad
llwell
mtt
methyl
thiazolyl
tetrazolium
mgml
ph
huashun
biotech
co
ltd
shanghai
pr
china
h
incub
supernat
well
remov
dmso
dimethyl
sulphoxid
ad
well
follow
min
shake
light
absorb
well
measur
nm
experi
repeat
three
time
duplic
clone
sequenc
fmdv
viral
rna
extract
cell
infect
fmdv
use
bodi
fluid
viral
dnavir
rna
miniprep
kit
vgene
biotechnolog
ltd
pr
china
viral
rna
revers
transcrib
cdna
use
exscript
tm
rt
reagent
kit
perfect
real
time
takara
accord
manufactur
manual
pcr
primer
pair
follow
sens
primer
antisens
primer
sens
primer
antisens
primer
sens
primer
antisens
primer
sens
primer
antisens
primer
purifi
pcr
product
clone
vector
recombin
clone
sequenc
big
dye
termin
cyclesequenc
use
amplif
primer
analyz
abi
prism
genet
analyz
appli
biosystem
accord
manufactur
protocol
sequenc
primer
sens
primer
antisens
primer
gene
sequenc
reconfirm
use
technelysium
pti
ltd
australia
sequenc
align
clustal
x
statist
comparison
experiment
group
control
group
perform
use
one
way
anova
dunnett
method
multipl
comparison
versu
control
group
p
less
regard
statist
signific
differ
data
present
mean
sd
quickli
effici
synthes
sirna
candid
target
sequenc
region
fmdv
genom
dna
oligonucleotid
templat
vitro
synthesi
rna
polymeras
design
obtain
sequenc
vitro
sirna
synthesi
whose
posit
first
nucleotid
design
correspond
sirna
name
suffix
sequenc
candid
two
complementari
rna
strand
synthes
dna
templat
anneal
form
sirna
produc
doublestrand
sirna
base
homolog
fmdv
overhang
uu
observ
found
intact
fig
monitor
fusion
protein
express
indic
interfer
sirna
candid
gene
clone
ctermin
egfp
tag
fig
construct
plasmid
transfect
hek
cell
use
accord
instruct
invitrogen
carlsbad
ca
usa
strong
fluoresc
observ
fluoresc
microscopi
h
transfect
fig
confirm
sequencespecif
silenc
sirna
design
sequenc
clone
upstream
egfp
gene
without
target
sequenc
sirna
high
level
fluoresc
observ
transfect
cell
imag
shown
thu
two
transient
express
system
transfect
suitabl
test
effici
inhibit
sequenc
specif
inhibit
sirna
respect
test
abil
sirna
inhibit
express
cotransfect
hek
cell
posit
control
neg
control
scrambledsirna
sirna
candid
target
along
express
plasmid
screen
test
result
identif
five
sirna
effect
inhibit
express
assess
fluoresc
microscop
observ
flow
cytometr
analysi
fig
show
signific
reduct
green
fluoresc
mean
fluoresc
intens
experi
nine
sirna
result
show
littl
inhibit
inhibit
imag
data
shown
replac
plasmid
contain
target
sequenc
five
sirna
target
similar
assay
reconduct
test
whether
inhibit
sirna
sequenc
specif
sirna
match
report
sequenc
reduct
green
fluoresc
mean
fluoresc
intens
induc
fig
result
confirm
observ
inhibit
express
occur
sequencespecif
manner
sinc
induc
high
level
inhibit
use
viral
challeng
analysi
examin
whether
sirna
synthes
vitro
could
inhibit
fmdv
replic
cell
cultur
cell
inocul
tcid
fmdv
follow
transfect
sirna
h
pi
amount
cell
well
triplic
harvest
rna
extract
serv
templat
realtim
rtqpcr
shown
fig
mean
rel
amount
viral
rna
transfect
scrambledsirna
respect
compar
level
viral
rna
controlexperi
cell
viral
challeng
without
treatment
sirna
obvious
mark
effect
inhibit
found
far
cell
transfect
addit
test
whether
combinatori
strategi
could
exert
enhanc
inhibitori
effect
mix
three
efficaci
sirna
togeth
equal
amount
perform
procedur
mean
rel
amount
viral
rna
transfect
mixtur
compar
control
addit
examin
fmdv
rna
replic
also
test
silenc
effect
fmdv
viru
sirna
yield
progeni
viru
h
pi
supernat
cell
titrat
plate
contain
cell
tcid
made
cytopath
effect
cpe
differ
dilut
harvest
viru
use
calcul
amount
viru
reed
muench
shown
fig
viru
yield
mocktransfect
cell
transfect
cell
scrambledsirna
similar
reach
maximum
h
pi
consist
result
obtain
viral
rna
quantit
cell
transfect
mixtur
display
markedli
lower
level
progeni
viru
cell
transfect
mockinfect
cell
two
control
sirna
h
pi
slight
low
level
progeni
viru
observ
cell
transfect
hand
show
almost
inhibit
yield
progeni
viru
importantli
observ
cpe
display
complet
detach
round
disintegr
cell
monolay
follow
h
pi
slight
cpe
emerg
mocktransfect
cell
transfect
cell
scrambledsirna
h
pi
extens
cpe
occupi
sampl
howev
emerg
slight
cpe
cell
transfect
mixtur
moder
cpe
h
pi
show
delay
approxim
h
respect
fig
h
pi
sampl
includ
mocktransfect
cell
transfect
cell
sirna
show
extens
cpe
viabil
percentag
detect
mtt
assay
show
obviou
elev
viabil
could
reach
group
mixtur
particularli
h
pi
fig
result
show
among
five
sirna
candid
valid
report
gene
assay
mixtur
mark
inhibitori
effect
replic
fmdv
although
delay
durat
inhibit
transient
signific
differ
mixtur
compon
term
inhibitori
efficaci
tabl
explor
retrospect
see
whether
variat
exist
gene
could
influenc
silenc
effect
sirna
candid
addit
also
randomli
compar
nucleotid
similar
gene
variant
wildtyp
gene
encod
structur
protein
intern
asymmetr
protom
ntermin
myrist
acid
gene
encod
vpg
number
level
viral
infect
correl
gene
product
thiolproteas
respons
cleavag
event
undergon
viral
polyprotein
also
proteolyt
process
histon
origin
supernat
collect
fmdvtransfect
cell
use
viru
infect
experi
subject
rapid
nucleotid
sequenc
brief
revers
transcript
fmdv
genom
rna
pcr
amplif
follow
molecular
clone
clone
sequenc
individu
clone
present
nucleotid
sequenc
shown
fig
variat
point
number
within
gene
nt
nucleotid
nt
nt
nt
nt
nt
respect
intriguingli
region
target
candid
sirna
contain
variat
despit
nucleotid
substitut
locat
nt
gene
within
target
region
furthermor
anoth
variat
point
locat
nt
found
near
end
target
sequenc
explor
whether
singl
nucleotid
substitut
within
near
sirna
target
region
lead
resist
fmdv
sirna
made
report
gene
construct
variant
design
former
introduc
g
substitut
posit
temporarili
design
latter
introduc
c
substitut
temporarili
design
construct
cotransfect
correspond
sirna
hek
cell
report
gene
express
level
measur
flow
cytometri
analysi
h
shown
fig
nearli
obtain
increas
level
resist
compar
indic
singl
nucleotid
substitut
g
posit
nt
within
target
region
markedli
reduc
interf
effici
nevertheless
nucleotid
substitut
c
posit
nt
locat
outsid
target
region
show
signific
differ
report
gene
express
level
fig
notabl
repeat
assay
viral
rna
replic
viral
titer
cytopath
effect
use
viru
supernat
first
round
inhibit
initi
infect
result
show
efficaci
second
round
exhibit
almost
similar
level
first
round
separ
data
shown
mean
delay
virus
show
significantli
increas
resist
efficaci
sirna
test
sirna
target
fmdv
five
sirna
steadili
result
effect
specif
silenc
effect
report
assay
hek
cell
furthermor
among
five
sirna
candid
three
sirna
confirm
efficaci
transient
inhibit
replic
fmdv
cell
determin
rel
viral
amount
within
infect
cell
viru
titer
supernat
well
observ
emerg
cpe
first
use
inexpens
method
rna
polymerasedirect
vitro
transcript
obtain
sirna
target
fmdv
first
present
demonstr
silenc
exogen
endogen
gene
donz
picard
differ
previou
rnai
inhibit
fmdv
studi
chen
et
al
chen
et
al
de
lo
santo
et
al
kahana
et
al
antifmdv
rnai
molecul
produc
chemic
synthesi
shrnavector
express
explor
method
antifmdv
rnai
strategi
due
follow
consider
firstli
high
genet
phenotyp
variabl
fmdv
inevit
pose
need
screen
rel
larg
amount
sirna
efficaci
inhibit
amplif
fmdv
specif
fmd
outbreak
secondli
chemic
synthesi
sirna
involv
high
cost
larg
quantiti
shrna
clone
plasmid
viral
vector
timeconsum
guarante
suffici
inhibitori
effect
therefor
feasibl
begin
search
highli
effect
sirna
transient
rnai
experi
less
expens
faster
method
rna
polymerasedirect
vitro
transcript
although
search
highli
conserv
sequenc
would
best
strategi
viru
escap
like
kahana
et
al
done
reason
chose
region
gene
import
region
fmdv
immunogen
search
entir
sequenc
gene
accord
sequenc
requir
presenc
sequenc
target
rna
need
obtain
possibl
templat
sequenc
consequ
synthes
candid
sirna
efficaci
test
among
demonstr
signific
reduct
report
gene
mixtur
result
effici
inhibit
fmdv
replic
cell
delay
durat
inhibit
reach
h
term
emerg
maximum
viru
yield
complet
cpe
although
durat
inhibit
day
long
vectorbas
rnai
studi
chen
et
al
chen
et
al
efficaci
sirna
target
sequenc
identifi
addit
efficaci
sirna
treat
cell
sirna
mixtur
result
demonstr
inhibitori
effect
mixtur
fmdv
rna
replic
viral
titer
cpe
approxim
compon
sirna
reason
mixtur
exert
signific
increas
inhibitori
effect
three
highli
conserv
sirna
target
region
fmdv
genom
kahana
fig
inhibit
fmdv
replic
rel
amount
viral
rna
sirnatransfect
cell
cell
sixwel
plate
transfect
sirna
mixtur
h
inocul
tcid
fmdv
h
pi
half
sampl
use
rna
extract
determin
rel
amount
viral
rna
realtim
rtqpcr
normal
bactin
rel
amount
viral
rna
viral
challeng
cell
without
sirna
set
b
decreas
viru
yield
cell
design
time
pi
cultur
supernat
collect
time
point
h
pi
viru
yield
measur
tcid
titer
yaxi
shown
log
tcid
ml
error
bar
repres
standard
deviat
three
independ
experi
p
vs
scrambledsirna
group
et
al
follow
firstli
three
efficaci
sirna
randomli
screen
without
consider
sequenc
conserv
secondli
three
sirna
constitut
mixtur
might
possess
equal
efficaci
inhibit
replic
fmdv
reason
enhanc
resist
efficaci
sirna
found
second
round
infect
opinion
might
follow
first
import
factor
viru
escap
efficaci
sirna
experi
might
quasispeci
fmdv
new
emerg
resist
variant
result
show
inhibitori
effect
efficaci
sirna
persist
longer
h
postinfect
could
allow
occurr
larg
number
mutant
despit
high
mutat
rate
fmdv
second
restrict
transfect
effici
sirna
could
guarante
complet
occup
sirna
cell
infect
fmdv
moreov
rel
quick
speed
degrad
sirna
could
persist
long
enough
efficaci
concentr
rais
possibl
viru
escap
furthermor
detail
analysi
mutat
fmdv
emphas
order
rais
specif
measur
facilit
rnai
surmount
viral
escap
ultim
reduc
efficaci
longterm
inhibit
studi
quasispeci
dynam
possibl
high
mutat
rate
fmdv
rna
might
facilit
escap
fmdv
sirna
character
high
degre
sequenc
specif
observ
differ
variant
exist
supernat
viral
infect
cell
particularli
test
singl
nucleotid
substitut
g
found
within
target
region
main
factor
caus
mark
decreas
antifmdv
efficaci
moreov
although
singl
nucleotid
substitut
c
near
target
region
result
resist
target
sequenc
absolut
deni
possibl
exist
variat
within
target
sequenc
could
identifi
molecular
clone
sequenc
clone
also
possibl
c
substitut
could
affect
rna
structur
affect
access
risc
fmdv
rna
effici
interfer
studi
escap
mutant
virus
westerhout
et
al
reveal
nucleotid
substitut
delet
sirna
target
sequenc
also
mutat
outsid
target
region
stabil
repress
structur
viral
rna
genom
could
mediat
escap
rnai
variat
within
identifi
us
locat
target
sequenc
addit
restrict
transfect
effici
rel
quick
speed
degrad
sirna
could
guarante
sirna
enter
fmdvinfect
cell
persist
long
enough
efficaci
concentr
rais
possibl
viru
escap
asid
factor
reason
fluctuat
inhibit
effici
exist
report
assay
viral
challeng
assay
studi
particularli
inefficaci
fmdv
challeng
cell
presum
follow
differ
spatial
structur
report
plasmid
fmdv
genom
rna
might
affect
access
rnainduc
silenc
complex
risc
combin
practic
use
sirna
rnai
viru
infect
rnai
therapi
fmdv
infect
hiv
infect
bennass
et
al
brass
et
al
depend
overcom
coupl
crucial
obstacl
includ
establish
longterm
express
sirna
without
offtarget
effect
method
counteract
mutant
escap
virus
fortun
mani
strategi
nonvir
viral
vectorbas
express
shrna
vivo
select
conserv
sequenc
combinatori
use
sever
viral
andor
feasibl
cellular
target
exploit
overcom
problem
brass
et
al
gier
et
al
promisingli
human
preclin
studi
clinic
trial
exhibit
satisfi
result
term
toler
inhibitori
activ
vivo
devincenzo
et
al
meyer
et
al
practic
use
sirna
rnai
promis
futur
notic
sirna
rnai
probabl
use
condit
vaccin
drug
unavail
inadequ
manjunath
et
al
conclus
result
show
replic
fmdv
could
transient
inhibit
obtain
rna
polymerasedirect
vitro
transcript
also
fmdv
could
rapidli
escap
transient
inhibit
rnai
due
singl
nucleotid
substitut
within
target
sequenc
multipl
variant
quasispeci
fmdv
necess
strategi
aris
